<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Maloney</surname>
    <given-names>DG</given-names>
   </name>
   <name>
    <surname>Grillo-Lopez</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>CA</given-names>
   </name>
   <name>
    <surname>Bodkin</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Schilder</surname>
    <given-names>RJ</given-names>
   </name>
   <name>
    <surname>Neidhart</surname>
    <given-names>JA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma</article-title>
  <source>Blood.</source>
  <year>1997</year>
  <volume>90</volume>
  <fpage>2188</fpage>
  <lpage>2195</lpage>
  <pub-id pub-id-type="doi">10.1182/blood.V90.6.2188</pub-id>
  <?supplied-pmid 9310469?>
  <pub-id pub-id-type="pmid">9310469</pub-id>
 </element-citation>
</ref>
